Author Correction: NFS1 undergoes positive selection in lung tumours and protects cells from ferroptosis (Nature, (2017), 551, 7682, (639-643), 10.1038/nature24637);NFS1 undergoes positive selection in lung tumours and protects cells from ferroptosis

Nature

Volumn 551, Issue 7682, 2017, Pages 639-643

  Alvarez, Samantha W ^a   Sviderskiy, Vladislav O ^a   Terzi, Erdem M ^a   Papagiannakopoulos, Thales ^a   Moreira, Andre L ^a   Adams, Sylvia ^a   Sabatini, David M ^b,c   Birsoy, Kivanc ^b,c,d   Possemato, Richard ^a,b,c  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^d ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE; ENZYME; GLUTATHIONE; IRON SULFUR PROTEIN; NFS1; OXYGEN; REACTIVE OXYGEN METABOLITE; RNA; UNCLASSIFIED DRUG; LYASE; NFS1 PROTEIN, HUMAN; NFS1 PROTEIN, MOUSE;

ANATOMY; CANCER; CELLS AND CELL COMPONENTS; CONCENTRATION (COMPOSITION); ENZYME; ENZYME ACTIVITY; GENE; GENE EXPRESSION; GENOMICS; GROWTH; INHIBITION; METABOLISM; OXIDATION; OXYGEN; PROTEIN; RNA; TUMOR;

ARTICLE; BIOSYNTHESIS; CANCER INHIBITION; CELL DEATH; CONTROLLED STUDY; FENTON REACTION; FERROPTOSIS; GENE AMPLIFICATION; GENE EXPRESSION; GENOME; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG ADENOCARCINOMA; LUNG METASTASIS; MICROMETASTASIS; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; OXYGEN CONCENTRATION; OXYGEN CONSUMPTION; OXYGEN TENSION; PRIORITY JOURNAL; RNA INTERFERENCE; STREPTOCOCCUS PYOGENES; ANIMAL; DRUG EFFECTS; GENETICS; LUNG TUMOR; METABOLISM; METASTASIS; MOUSE; NON SMALL CELL LUNG CANCER; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; CARBON-SULFUR LYASES; CARCINOMA, NON-SMALL-CELL LUNG; CELL DEATH; CELL LINE, TUMOR; CYSTEINE; GLUTATHIONE; HUMANS; IRON-SULFUR PROTEINS; LUNG NEOPLASMS; MICE; NEOPLASM METASTASIS; OXIDATIVE STRESS; OXYGEN; RNA INTERFERENCE;

EID: 85036582367     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/s41586-022-05323-7     Document Type: Erratum

References (34)

1. Birsoy, K. et al. Metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides. Nature 508, 108-112 (2014).
2. Davidson, S. M. et al. Environment impacts the metabolic dependencies of Ras-driven non-small cell lung cancer. Cell Metab. 23, 517-528 (2016).
3. Kamphorst, J. J. et al. Hypoxic and Ras-transformed cells support growth by scavenging unsaturated fatty acids from lysophospholipids. Proc. Natl Acad. Sci. USA 110, 8882-8887 (2013).
4. Vaupel, P., Kallinowski, F. & Okunieff, P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: A review. Cancer Res. 49, 6449-6465 (1989).
5. Stehling, O., Wilbrecht, C. & Lill, R. Mitochondrial iron-sulfur protein biogenesis and human disease. Biochimie 100, 61-77 (2014).
6. Netz, D. J., Mascarenhas, J., Stehling, O., Pierik, A. J. & Lill, R. Maturation of cytosolic and nuclear iron-sulfur proteins. Trends Cell Biol. 24, 303-312 (2014).
7. Imlay, J. A. Iron-sulfur clusters and the problem with oxygen. Mol. Microbiol. 59, 1073-1082 (2006).
8. Marchler-Bauer, A. et al. CDD: NCBI's conserved domain database. Nucleic Acids Res. 43, D222-D226 (2015).
9. Paul, V. D. & Lill, R. Biogenesis of cytosolic and nuclear iron-sulfur proteins and their role in genome stability. Biochim. Biophys. Acta 1853, 1528-1539 (2015).
10. Marelja, Z., Stöcklein, W., Nimtz, M. & Leimkühler, S. A novel role for human Nfs1 in the cytoplasm: Nfs1 acts as a sulfur donor for MOCS3, a protein involved in molybdenum cofactor biosynthesis. J. Biol. Chem. 283, 25178-25185 (2008).
11. Vaupel, P., Schlenger, K., Knoop, C. & Höckel, M. Oxygenation of human tumors: evaluation of tissue oxygen distribution in breast cancers by computerized O2 tension measurements. Cancer Res. 51, 3316-3322 (1991).
12. Zack, T. I. et al. Pan-cancer patterns of somatic copy number alteration. Nat. Genet. 45, 1134-1140 (2013).
13. De Coo, I. F. et al. A 4-base pair deletion in the mitochondrial cytochrome b gene associated with parkinsonism/MELAS overlap syndrome. Ann. Neurol. 45, 130-133 (1999).
14. van Loon, A. P., Pesold-Hurt, B. & Schatz, G. A yeast mutant lacking mitochondrial manganese-superoxide dismutase is hypersensitive to oxygen. Proc. Natl Acad. Sci. USA 83, 3820-3824 (1986).
15. Bilinski, T., Krawiec, Z., Liczmanski, A. & Litwinska, J. Is hydroxyl radical generated by the Fenton reaction in vivo Biochem. Biophys. Res. Commun. 130, 533-539 (1985).
16. Flint, D. H., Emptage, M. H., Finnegan, M. G., Fu, W. & Johnson, M. K. The role and properties of the iron-sulfur cluster in Escherichia coli dihydroxy-acid dehydratase. J. Biol. Chem. 268, 14732-14742 (1993).
17. Casey, J. L. et al. Iron-responsive elements: regulatory RNA sequences that control mRNA levels and translation. Science 240, 924-928 (1988).
18. Meyron-Holtz, E. G., Ghosh, M. C. & Rouault, T. A. Mammalian tissue oxygen levels modulate iron-regulatory protein activities in vivo. Science 306, 2087-2090 (2004).
19. Chandel, N. S. et al. Mitochondrial reactive oxygen species trigger hypoxiainduced transcription. Proc. Natl Acad. Sci. USA 95, 11715-11720 (1998).
20. Minotti, G. & Aust, S. D. The role of iron in oxygen radical mediated lipid peroxidation. Chem. Biol. Interact. 71, 1-19 (1989).
21. Yang, W. S. & Stockwell, B. R. Ferroptosis: death by lipid peroxidation. Trends Cell Biol. 26, 165-176 (2016).
22. Yang, W. S. et al. Regulation of ferroptotic cancer cell death by GPX4. Cell 156, 317-331 (2014).
23. Dixon, S. J. et al. Ferroptosis: An iron-dependent form of nonapoptotic cell death. Cell 149, 1060-1072 (2012).
24. Cramer, S. L. et al. Systemic depletion of l-cyst(e)ine with cyst(e)inase increases reactive oxygen species and suppresses tumor growth. Nat. Med. 23, 120-127 (2017).
25. Harris, I. S. et al. Glutathione and thioredoxin antioxidant pathways synergize to drive cancer initiation and progression. Cancer Cell 27, 211-222 (2015).
26. Possemato, R. et al. Functional genomics reveal that the serine synthesis pathway is essential in breast cancer. Nature 476, 346-350 (2011).
27. Carpenter, A. E. et al. CellProfiler: image analysis software for identifying and quantifying cell phenotypes. Genome Biol. 7, R100 (2006).
28. Beroukhim, R. et al. The landscape of somatic copy-number alteration across human cancers. Nature 463, 899-905 (2010).
29. Okayama, H. et al. Identification of genes upregulated in ALK-positive and EGFR/KRAS/ALK-negative lung adenocarcinomas. Cancer Res. 72, 100-111 (2012).
30. Barretina, J. et al. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature 483, 603-607 (2012).
31. DuPage, M., Dooley, A. L. & Jacks, T. Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinase. Nat. Protocols 4, 1064-1072 (2009).
32. Lee, M. et al. AMP-activated protein kinase activity is critical for hypoxiainducible factor-1 transcriptional activity and its target gene expression under hypoxic conditions in DU145 cells. J. Biol. Chem. 278, 39653-39661 (2003).
33. Maxwell, P. H. et al. The tumour suppressor protein VHL targets hypoxiainducible factors for oxygen-dependent proteolysis. Nature 399, 271-275 (1999).
34. Wang, T. et al. Identification and characterization of essential genes in the human genome. Science 350, 1096-1101 (2015).